Keith Pfeil Net Worth

The estimated Net Worth of Keith W Pfeil is at least $2.81 Milión dollars as of 2 February 2023. Mr. Pfeil owns over 29,167 units of Globus Medical Inc stock worth over $2,020,398 and over the last 6 years he sold GMED stock worth over $0. In addition, he makes $787,667 as Chief Financial Officer a Senior Vice President at Globus Medical Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Pfeil GMED stock SEC Form 4 insiders trading

Keith has made over 8 trades of the Globus Medical Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 29,167 units of GMED stock worth $1,502,392 on 2 February 2023.

The largest trade he's ever made was exercising 29,167 units of Globus Medical Inc stock on 2 February 2023 worth over $1,502,392. On average, Keith trades about 3,893 units every 79 days since 2018. As of 2 February 2023 he still owns at least 29,167 units of Globus Medical Inc stock.

You can see the complete history of Mr. Pfeil stock trades at the bottom of the page.

Keith Pfeil biography

Keith W. Pfeil serves as Chief Financial Officer, Senior Vice President of the Company. Mr. Pfeil joins the Company after almost 16 years at CSS Industries, a publicly traded consumer products company, in which he served in a number of financial leadership roles, most recently as Executive Vice President and Chief Financial Officer. Mr. Pfeil’s financial leadership experience includes experience with financial planning and analysis, internal audit and investor relations. Prior to CSS Industries, Mr. Pfeil worked in the transaction advisory practice of Ernst and Young LLP, and prior to that he worked in the assurance practices of KPMG LLP and Arthur Andersen LLP. Mr. Pfeil holds an Executive Masters of Business Administration from Saint Joseph’s University and a Bachelor of Science in accounting from Elizabethtown College.

What is the salary of Keith Pfeil?

As the Chief Financial Officer a Senior Vice President of Globus Medical Inc, the total compensation of Keith Pfeil at Globus Medical Inc is $787,667. There are 7 executives at Globus Medical Inc getting paid more, with David Demski having the highest compensation of $3,449,790.

How old is Keith Pfeil?

Keith Pfeil is 41, he's been the Chief Financial Officer a Senior Vice President of Globus Medical Inc since 2019. There are 18 older and no younger executives at Globus Medical Inc. The oldest executive at Globus Medical Inc is James Tobin, 75, who is the Independent Director.

What's Keith Pfeil's mailing address?

Keith's mailing address filed with the SEC is 450 Plymouth Rd, Plymouth Meeting, PA 19462, USA.

Insiders trading at Globus Medical Inc

Over the last 12 years, insiders at Globus Medical Inc have traded over $375,265,297 worth of Globus Medical Inc stock and bought 2,005 units worth $99,824 . The most active insiders traders include David C Paul, Kurt Wheeler a David M Demski. On average, Globus Medical Inc executives and independent directors trade stock every 42 days with the average trade being worth of $11,005,133. The most recent stock trade was executed by Leslie V Norwalk on 11 July 2024, trading 1,000 units of GMED stock currently worth $70,000.

What does Globus Medical Inc do?

globus medical, inc. is a leading musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. founded in 2003, globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with spinal disorders. additional information can be accessed at www.globusmedical.com.

Complete history of Mr. Pfeil stock trades at Globus Medical Inc

Globus Medical Inc executives and stock owners

Globus Medical Inc executives and other stock owners filed with the SEC include:

• David Demski,
  President, Chief Executive Officer, Director
• David Paul,
  Executive Chairman of the Board
• Daniel Scavilla,
  Executive Vice President, Chief Commercial Officer
• David M. Demski,
  CEO, Pres & Director
• Kelly Huller,
  Senior Vice President, General Counsel, Corporate Secretary
• David C. Paul,
  Co-Founder & Exec. Chairman
• Daniel T. Scavilla,
  Exec. VP, Chief Commercial Officer & Pres of Trauma
• Keith Pfeil,
  Chief Financial Officer, Senior Vice President
• Keith W. Pfeil,
  Sr. VP & CFO
• Kelly G. Huller Esq.,
  Sr. VP & Gen. Counsel
• Ann Rhoads,
  Independent Director
• Robert Douglas,
  Independent Director
• James Tobin,
  Independent Director
• Daniel Lemaitre,
  Independent Director
• Steve Zarrilli,
  Independent Director
• David Davidar,
  Independent Director
• Richard Holifield,
  Exec. Officer
• Mike Reeder,
  Exec. Officer
• Steven M. Payne,
  VP & Controller
• A. Brett Murphy,
  Exec. VP of International Sales
• Brian J. Kearns,
  Sr. VP of Bus. Devel. & Investor Relations
• John A De Ford,
  
• Kurt Wheeler,
  Director
• Robert Liptak,
  Director
• Steven Payne,
  Chief Accounting Officer
• Anthony L Williams,
  President
• Stephen T Zarrilli,
  
• Leslie V Norwalk,
  
• Dan Wolterman,
  
• Dan Lemaitre,
  
• A Brett Murphy,
  Executive VP, US Sales
• Eric Schwartz,
  Senior VP and General Counsel
• Sachs & Cogoldman Sachs Gro...,
  
• Lifesciences I, L.P.Clarus ...,
  
• Sachs Pep 2004 Offshore Hol...,
  
• Richard A Baron,
  Senior VP and CFO
• Sachs Group Incgoldman Sach...,
  
• Sachs Private Equity Partne...,